Podcast Episode
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Selecting Glucose Lowering Therapy
About this episode
In this episode, we review the 2026 Consensus Statement algorithm for selecting glucose lowering therapy in adults with type 2 diabetes, focusing on cardiovascular, heart failure, kidney, liver, weight, hypoglycemia, adverse effect, and cost considerations. Topics include medication efficacy, cardiovascular and cardiorenal benefits, weight effects, MASLD and MASH, renal dosing, adverse effects, and individualized treatment selection.